Intraalveolar catecholamines and the human lung microbiome

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 2, 2015, Pages 257-259

  Dickson, Robert P ^a   Erb Downward, John R ^a   Prescott, Hallie C ^a   Martinez, Fernando J ^b   Curtis, Jeffrey L ^a,c   Lama, Vibha N ^a   Huffnagle, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; NORADRENALIN;

BRONCHOSCOPY; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LUNG ALVEOLUS; LUNG LAVAGE; MICROBIAL COMMUNITY; MICROBIOME; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; BRONCHOALVEOLAR LAVAGE FLUID; LUNG; METABOLISM; MICROBIOLOGY; MICROFLORA;

BRONCHOALVEOLAR LAVAGE FLUID; CATECHOLAMINES; HUMANS; LUNG; MICROBIOTA;

EID: 84938074836     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201502-0326LE     Document Type: Letter

References (10)

1. Mizgerd JP. Lung infection - a public health priority. PLoS Med 2006;3:e76.
2. Dickson RP, Erb-Downward JR, Huffnagle GB. Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Respir Med 2014;2:238-246.
3. Dickson RP, Martinez FJ, Huffnagle GB. The role of the microbiome in exacerbations of chronic lung diseases. Lancet 2014;384:691-702.
4. Freestone PP, Hirst RA, Sandrini SM, Sharaff F, Fry H, Hyman S, O'Callaghan C. Pseudomonas aeruginosa-catecholamine inotrope interactions: a contributory factor in the development of ventilator-associated pneumonia? Chest 2012;142:1200-1210.
5. Lyte M, Ernst S. Catecholamine induced growth of gram negative bacteria. Life Sci 1992;50:203-212.
6. Marks LR, Davidson BA, Knight PR, Hakansson AP. Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease. MBio 2013;4:4.
7. Dickson RP, Erb-Downward JR, Freeman CM, Walker N, Scales BS, Beck JM, Martinez FJ, Curtis JL, Lama VN, Huffnagle GB. Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations. PLoS One 2014;9:e97214.
8. Dickson RP, Erb-Downward JR, Prescott HC, Martinez FJ, Curtis JL, Lama VN, Huffnagle GB. Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid. J Clin Microbiol 2014;52:3605-3613.
9. Scales BS, Dickson RP, LiPuma JJ, Huffnagle GB. Microbiology, genomics, and clinical significance of the Pseudomonas fluorescens species complex, an unappreciated colonizer of humans. Clin Microbiol Rev 2014;27:927-948.
10. Flierl MA, Rittirsch D, Nadeau BA, Chen AJ, Sarma JV, Zetoune FS, McGuire SR, List RP, Day DE, Hoesel LM, et al. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 2007;449:721-725.